Literature DB >> 30663717

Investigation of Genetic Dependencies Using CRISPR-Cas9-based Competition Assays.

Anagha Deshpande1, Bo Rui Chen1, Luyi Zhao1, Kelsey Saddoris1, Mayuri Kerr1, Nan Zhu2, Prashant Mali3, Aniruddha J Deshpande4.   

Abstract

Gene perturbation studies have been extensively used to investigate the role of individual genes in AML pathogenesis. For achieving complete gene disruption, many of these studies have made use of complex gene knockout models. While these studies with knockout mice offer an elegant and time-tested system for investigating genotype-to-phenotype relationships, a rapid and scalable method for assessing candidate genes that play a role in AML cell proliferation or survival in AML models will help accelerate the parallel interrogation of multiple candidate genes. Recent advances in genome-editing technologies have dramatically enhanced our ability to perform genetic perturbations at an unprecedented scale. One such system of genome editing is the CRISPR-Cas9-based method that can be used to make rapid and efficacious alterations in the target cell genome. The ease and scalability of CRISPR/Cas9-mediated gene-deletion makes it one of the most attractive techniques for the interrogation of a large number of genes in phenotypic assays. Here, we present a simple assay using CRISPR/Cas9 mediated gene-disruption combined with high-throughput flow-cytometry-based competition assays to investigate the role of genes that may play an important role in the proliferation or survival of human and murine AML cell lines.

Entities:  

Mesh:

Year:  2019        PMID: 30663717     DOI: 10.3791/58710

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  1 in total

1.  A systematic genome-wide mapping of oncogenic mutation selection during CRISPR-Cas9 genome editing.

Authors:  Sanju Sinha; Karina Barbosa; Kuoyuan Cheng; Mark D M Leiserson; Prashant Jain; Anagha Deshpande; David M Wilson; Bríd M Ryan; Ji Luo; Ze'ev A Ronai; Joo Sang Lee; Aniruddha J Deshpande; Eytan Ruppin
Journal:  Nat Commun       Date:  2021-11-11       Impact factor: 17.694

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.